title: L/N-type calcium channel blocker cilnidipine added to renin-angiotensin inhibition improves ambulatory blood pressure profile and suppresses cardiac hypertrophy in hypertension with chronic kidney disease.
abstract: Ambulatory blood pressure (BP) and heart rate (HR) profile are proposed to be related to renal deterioration and cardiovascular complication in hypertension and chronic kidney disease (CKD). In this study, we examined the beneficial effects cilnidipine, a unique L/N-type calcium channel blocker (CCB), in addition to renin-angiotensin system inhibitors, on ambulatory BP and HR profile, as well as cardiorenal function in hypertensive CKD patients. Forty-five patients were randomly assigned to the cilnidipine replacement group (n = 21) or the control CCBs group (n = 24) during a 24-week active treatment period. Although clinical BP values were similar in the cilnidipine and control CCBs groups after the treatment period, the results of ambulatory BP monitoring showed that the 24-h and daytime systolic BP levels in the cilnidipine group were significantly lower compared with the control group after the study. Furthermore, the left ventricular mass index (LVMI) was significantly decreased in the cilnidipine group compared to the control group after the study (LVMI, 135.3 ± 26.4 versus 181.2 ± 88.4, p = 0.031), with a significant difference in the changes in the LVMI between the cilnidipine and control groups (change in LVMI, -12.4 ± 23.7 versus 26.2 ± 64.4, p = 0.007). These results indicate that cilnidipine is beneficial for the suppression of pathological cardiac remodeling, at least partly, via a superior improving effect on ambulatory BP profile compared with control CCBs in hypertensive CKD patients.
authors: Department of Medical Science and Cardiorenal Medicine, Graduate School of Medicine, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama 236-0004, Japan.
authors: Tomohiko
authors: T
authors: Kanaoka
authors: Kouichi
authors: K
authors: Tamura
authors: Hiromichi
authors: H
authors: Wakui
authors: Masato
authors: M
authors: Ohsawa
authors: Kengo
authors: K
authors: Azushima
authors: Kazushi
authors: K
authors: Uneda
authors: Ryu
authors: R
authors: Kobayashi
authors: Tetsuya
authors: T
authors: Fujikawa
authors: Yuko
authors: Y
authors: Tsurumi-Ikeya
authors: Akinobu
authors: A
authors: Maeda
authors: Mai
authors: M
authors: Yanagi
authors: Yoshiyuki
authors: Y
authors: Toya
authors: Satoshi
authors: S
authors: Umemura
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D057911:Angiotensin Receptor Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D018660:Blood Pressure Monitoring, Ambulatory; D002121:Calcium Channel Blockers / Q000494:pharmacology / Q000627:therapeutic use; D020746:Calcium Channels, L-Type / Q000378:metabolism; D020864:Calcium Channels, N-Type / Q000378:metabolism; D006332:Cardiomegaly / Q000188:drug therapy* / Q000503:physiopathology; D004095:Dihydropyridines / Q000494:pharmacology / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D051436:Renal Insufficiency, Chronic / Q000188:drug therapy / Q000503:physiopathology*; D012084:Renin-Angiotensin System / Q000187:drug effects; D016896:Treatment Outcome
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D020746:Calcium Channels, L-Type; D020864:Calcium Channels, N-Type; D004095:Dihydropyridines; C065927:cilnidipine
references: Hypertens Res. 2009 May;32(5):392-8
references: 19373239
references: Int J Cardiol. 2009 Jan 24;131(3):370-7
references: 18199499
references: Arch Intern Med. 2011 Jun 27;171(12):1090-8
references: 21709109
references: Am J Cardiovasc Dis. 2011;1(3):236-43
references: 22254201
references: J Hypertens. 2010 Oct;28(10):2156-60
references: 20625317
references: Kidney Int. 2007 Dec;72(12):1543-9
references: 17943080
references: J Clin Hypertens (Greenwich). 2012 Aug;14(8):522-9
references: 22863160
references: Am J Physiol Heart Circ Physiol. 2007 Jul;293(1):H798-804
references: 17434976
references: Nephrol Dial Transplant. 2012 Feb;27(2):700-9
references: 21765187
references: J Clin Hypertens (Greenwich). 2013 Feb;15(2):133-42
references: 23339732
references: Diabetes. 1993 Dec;42(12):1745-52
references: 8243821
references: Kidney Int. 2004 May;65(5):1568-76
references: 15086894
references: BMJ. 2011 Jun 24;342:d3621
references: 21705406
references: Hypertension. 1999 Jun;33(6):1447-52
references: 10373231
references: Nephron Clin Pract. 2009;112(1):c31-40
references: 19342867
references: Diabetes Care. 2010 Jul;33(7):1578-84
references: 20215456
references: Atherosclerosis. 2009 Nov;207(1):186-90
references: 19423110
references: Circulation. 1994 Jul;90(1):234-40
references: 8026003
references: Hypertension. 2000 Nov;36(5):901-6
references: 11082164
references: Diabetes Res Clin Pract. 2012 Jul;97(1):91-8
references: 22336632
references: Hypertens Res. 2011 Feb;34(2):268-73
references: 21124330
references: Am J Nephrol. 2012;35(5):416-23
references: 22517217
references: Hypertens Res. 2010 Jun;33(6):521-8
references: 20339374
references: Hypertens Res. 2005 Dec;28(12):1003-8
references: 16671340
references: Curr Hypertens Rep. 2013 Apr;15(2):95-101
references: 23354877
references: Br J Clin Pharmacol. 2000 Dec;50(6):615-20
references: 11136301
references: J Hum Hypertens. 2007 Feb;21(2):135-40
references: 17096005
references: Nephrol Dial Transplant. 2001;16 Suppl 1:67-9
references: 11369825
references: Eur J Pharmacol. 2002 Jan 2;434(1-2):43-7
references: 11755164
references: Hypertens Res. 2009 Nov;32(11):950-5
references: 19713965
references: Lancet. 2011 Oct 1;378(9798):1219-30
references: 21868086
references: Hypertens Res. 2013 Mar;36(3):262-9
references: 23154587
references: Blood Press. 2012 Jul;21 Suppl 1:3-10
references: 22762301
references: Hypertens Res. 1998 Sep;21(3):215-9
references: 9786607
references: Hypertens Res. 2002 May;25(3):359-64
references: 12135313
references: Clin Exp Hypertens. 2011;33(4):255-63
references: 21699452
references: Hypertens Res. 2000 Jul;23(4):311-6
references: 10912766
references: Am J Kidney Dis. 2009 Jun;53(6):982-92
references: 19339088